Duality Advisers’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10,683
| Closed | -$1M | – | 575 |
|
|
2023
Q3 | $1M | Buy |
10,683
+4,595
| +75% | +$430K | 0.12% | 288 |
|
|
2023
Q2 | $543K | Buy |
+6,088
| New | +$543K | 0.07% | 379 |
|
|
2022
Q1 | – | Sell |
-2,526
| Closed | -$340K | – | 627 |
|
|
2021
Q4 | $340K | Buy |
+2,526
| New | +$340K | 0.04% | 435 |
|
|
2021
Q3 | – | Sell |
-5,439
| Closed | -$716K | – | 525 |
|
|
2021
Q2 | $716K | Sell |
5,439
-3,955
| -42% | -$521K | 0.06% | 390 |
|
|
2021
Q1 | $1.21M | Buy |
9,394
+6,286
| +202% | +$810K | 0.11% | 308 |
|
|
2020
Q4 | $518K | Buy |
+3,108
| New | +$518K | 0.04% | 441 |
|